The Effect of Survival, Response and Microbiota Change in Different Therapy Under Probiotic Supplement

Launched by CHANG GUNG MEMORIAL HOSPITAL · May 22, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the potential benefits of a specific probiotic called Clostridium butyricum in patients undergoing cancer treatment. Probiotics are good bacteria that can help improve our gut health and may support the immune system, which is important for fighting cancer. The researchers want to see if taking this probiotic can enhance the effectiveness of different cancer therapies, such as chemotherapy or immunotherapy, and improve patients' overall health and survival.

To participate in the trial, you need to be at least 20 years old and currently receiving treatment for cancer, with a confirmed diagnosis. If you join, you can expect to take the probiotic supplement while continuing your cancer treatment, and the researchers will monitor your health and response to the therapy. This study aims to understand how probiotics can play a role in cancer care, especially in improving treatment outcomes for patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. age≧20
• • 2. participants with cancer therapy and agree to sign informed consent
• • 3. Cancer confirmed by clinical or pathological diagnosis
• Exclusion Criteria:
• • 1. age\<20
• • 2. Pregnant or breastfeeding women